Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis

Journal of Digestive Diseases

Volumn 10, Issue 3, 2009, Pages 201-206

  Lesmana, C Rinaldi A ^a   Hasan, Irsan ^a   Budihusodo, Unggul ^a   Gani, Rino A ^a   Krisnuhoni, Ening ^a   Akbar, Nurul ^a   Lesmana, Laurentius A ^a  

^a UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Hyaluronic acid; Insulin resistance; NASH; TNF ; Type IV collagen

Indexed keywords

ALANINE AMINOTRANSFERASE; COLLAGEN TYPE 4; HYALURONIC ACID; INSULIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; COLLAGEN TYPE IV; FATTY LIVER; FEMALE; HUMANS; HYALURONIC ACID; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 68149182338     PISSN: 17512972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2009.00386.x     Document Type: Article

References (23)

1. Poynard T, Ratziu V, Charlotte F et al. Diagnostic value of biochemical markers (NashTest) for the prediction of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006; 6: 34.
2. Ratziu V, Massard J, Charlotte F et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006; 6: 6.
3. Li Z, Diehl AM. Cytokines and inflammatory recruitment in NASH: experimental and human studies. In: Farrell GC, George J, Hall PM, McCullough AJ, eds. Fatty Liver Disease: NASH and Related Disorder. Oxford: Blackwell, 2005; 123-31.
4. Diehl AM, Li ZP, Lin HZ, Yang SQ. Cytokines and the pathogenesis of non-alcoholic steatohepatitis. Gut. 2005; 54: 303-6.
5. Parés A, Deulofeu R, Giemenez A et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology. 1996; 24: 1399-403.
6. Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyalurona and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem. 1996; 42: 558-63.
7. McHutchinson JG, Blatt LM, de Medina M et al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol. 2000; 15: 945-51.
8. Takamatsu S, Nakabayashi H, Okamoto Y, Nakano Y. Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables. J Gastroenterol. 1997; 32: 355-60.
9. Marceau P, Biron S, Hould FS et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 1999; 84: 1513-7.
10. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001; 121: 91-100.
11. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999; 94: 2467-74.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-9.
13. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998; 21: 2191-2.
14. Dos Santos VN, Leite-Mór MMB, Kondo M et al. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. Braz J Med Biol Res. 2005; 38: 747-53.
15. Sakugawa H, Nakayoshi T, Kobashigawa K et al. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J Gastroenterol. 2005; 11: 255-9.
16. Yoneda M, Mawatari H, Fujita K et al. Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. J Gastroenterol. 2007; 42: 375-81.
17. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic liver steatohepatitis. N Engl J Med. 2000; 343: 1467-78.
18. Bahcecioglu IH, Yalniz M, Ataseven H et al. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis. Hepatogastroenterology. 2005; 52: 1549-53.
19. Xie SB, Yao JL, Zheng RQ, Peng XM, Gao ZL. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. HPBD Int. 2003; 2: 69-72.
20. Suzuki A, Angulo P, Lymp J, Li D, Satomura S, Lindor K. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int. 2005; 25: 779-86.
21. Lydatakis H, Hager IP, Kostadelou E, Mpousmpoulas S, Pappas S, Diamantis I. Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease. Liver Int. 2006; 26: 864-71.
22. Shimada M, Kawahara H, Ozaki K et al. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatoheptitis. Am J Gastroenterol. 2007; 102: 1931-8.
23. Sakurai M, Takamura T, Ota T et al. Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. J Gastroenterol. 2007; 42: 312-7.